High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.6M
$2,626,262
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-06 | $853,993x12 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Huntsman Carole
• Officer • Chief Commercial Officer
Sell to Cover
2026-03-06
$180,983
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2026-03-06 | $180,983 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Kelley Shannon T
• Officer • General Counsel
Sell to Cover
2026-03-06
$155,498
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Officer • General Counsel
Sell to Cover
|
2026-03-06 | $155,498 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-06 | $718,316 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Sell to Cover
|
2026-03-06 | $212,083 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
Sell to CoverΔOwn -11.3%
|
2026-03-02 | $505,389 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Other
|
2026-02-23 | $18,400 | M | Form 4 |